Utah Medical Products (UTMD) Accumulated Depreciation & Amortization (2016 - 2024)
Utah Medical Products (UTMD) has 14 years of Accumulated Depreciation & Amortization data on record, last reported at $23.9 million in Q4 2024.
- For Q4 2024, Accumulated Depreciation & Amortization rose 0.86% year-over-year to $23.9 million; the TTM value through Dec 2024 reached $23.9 million, up 0.86%, while the annual FY2024 figure was $23.9 million, 0.86% up from the prior year.
- Accumulated Depreciation & Amortization reached $23.9 million in Q4 2024 per UTMD's latest filing, up from $23.7 million in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $23.9 million in Q4 2024 and bottomed at $22.8 million in Q4 2021.
- Average Accumulated Depreciation & Amortization over 5 years is $23.3 million, with a median of $23.0 million recorded in 2020.
- Peak YoY movement for Accumulated Depreciation & Amortization: dropped 0.69% in 2021, then rose 3.39% in 2023.
- A 5-year view of Accumulated Depreciation & Amortization shows it stood at $23.0 million in 2020, then decreased by 0.69% to $22.8 million in 2021, then increased by 0.62% to $22.9 million in 2022, then increased by 3.39% to $23.7 million in 2023, then increased by 0.86% to $23.9 million in 2024.
- Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $23.9 million in Q4 2024, $23.7 million in Q4 2023, and $22.9 million in Q4 2022.